A team of researchers from the University of Florida has developed an innovative handheld device for human immunodeficiency ...

With its innovative self-amplifying mRNA (SAM-RNA) technology and strategic partnerships ... with H5N1 and recent cases of mammal-to-human transmission highlight the need for more effective ...

Through my research, I seek to promote advocacy and impact federal policy by amplifying the voices of people with diabetes ... To quantify the levels of DNMTs between GHR-/- and WT mice. We will ...

This study is the first to demonstrate that certain tRNA introns influence gene expression. Scientists have discovered that ...

Arcturus developed KOSTAIVE®, the first self-amplifying messenger RNA (sa-mRNA) COVID vaccine in the world to be approved. Arcturus has an ongoing global collaboration for innovative mRNA ...

Arcturus Therapeutics and CSL's COVID-19 vaccine Kostaive has been approved for marketing in the EU, becoming the first based on self-amplifying mRNA (sa-mRNA) to clear that threshold. While ...

today announced that the European Commission has granted marketing authorization for KOSTAIVE ® (ARCT-154), a self-amplifying mRNA COVID-19 vaccine, for individuals 18 years and older.

Unlike standard mRNA vaccines, self-amplifying mRNA vaccines instruct the body to make more mRNA and protein to boost the immune response.

Scientists have discovered that some tiny segments of RNA thought to be junk instead have a functional role in suppressing production of certain messenger RNAs and appear to help cells respond to ...